Comparison of the efficacy of domestic allergenic extracts with matched commercial imported extracts

Phase 2

Recruiting

• Conditions: Condition 1: Allergic rhinitis. Condition 2: Asthma. Condition 3: Atopic dermatitis. Condition 4: Food allergy.; Allergic rhinitis due to pollen; Asthma; Atopic dermatitis; Food allergy status; J30.1; Z91.01

• Registration Number: IRCT20181216042006N1
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 107

Inclusion Criteria

patients with history of allergy to inhalant or food allergens who visit allergy clinics and are candidate of performing skin prick test by specialist

Exclusion Criteria

Having serious health problems such as cancer, immunodeficiency, autoimmunity, cardiac disease and severe infection
Pregnancy or breastfeeding
History of anaphylaxis or uncontrolled asthma
Current dermatographism or urticaria
History of allergy immunotherapy during the last 5 years
Using medicine which interfere with skin prick test such as antihistamines, oral corticosteroids, narcotics or sedatives during the last week

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Positive skin reactivity to domestic extracts in comparison to commercial extracts. Timepoint: 15 minutes after doing skin prick test. Method of measurement: Area of wheal created by extracts in square milometers.

Secondary Outcome Measures

Name	Time	Method
Side effects of skin prick testing with commercial or domestic extracts including large local reactions or systemic reactions. Timepoint: during the first 24 hours after doing skin prick test. Method of measurement: A design questionnaire.